poractant alfa, a lung surfactant extract. ▪ INDICATIONS: It is used in the treatment (rescue) of respiratory distress syndrome in premature infants. ▪ CONTRAINDICATIONS: None is currently known. ▪ ADVERSE EFFECTS: Concurrent illnesses that have occurred during treatment with this drug include pulmonary air leaks, pulmonary interstitial emphysema, apnea, pulmonary hemorrhage, patent ductus arteriosus, intracranial hemorrhage, severe intracranial hemorrhage, necrotizing enterocolitis, posttreatment sepsis, and posttreatment infection. Adverse effects include bradycardia, oxygen desaturation, pallor, vasoconstriction, hypotension, and hypertension.
